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Abstract 
 35 
During the last decades, several studies have proposed manganese (Mn) complexes as 
alternative contrast agents for magnetic resonance imaging (MRI). With the 
nanotechnology surge in recent years, different types of Mn-based nanoparticles (Nps) 
have been developed. However, to design effective and safe administration procedures, 
preliminary studies on target cells, aimed at verify their full biocompatibility and 40 
biodegradability, are mandatory.  
In this study, MnO containing-Nps encapsulated in a phospholipidic shell (PL-MnO Nps) 
were tested in cultured cells and flow cytometry; confocal and transmission electron 
microscopy were combined to understand the Nps uptake mechanism, intracellular 
distribution and degradation pathways, as well as possible organelle alterations.  45 
The results demonstrated that PL-MnO Nps undergo rapid and massive cell 
internalization, and persist free in the cytoplasm before undergoing lysosomal degradation 
without being cytotoxic or inducing subcellular damage. Based on the results with this cell 
model in vitro, PL-MnO Nps thus proved to be suitably biocompatible, and may be 
envisaged as very promising tools for therapeutic and diagnostic applications, as drug 50 
carriers or contrast agent for MRI. 
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1. Introduction 60 
 
Manganese (Mn) is known as an essential trace element for many cellular processes; it is 
required for proper bone growth, reproduction, blood coagulation and hemostasis, immune 
function, regulation of blood sugar, protection against reactive oxygen species, and it is 
also necessary for normal brain and nerve function (Wedler and Denman, 1984; Patchett 65 
et al., 1991; Zwingmann et al., 2004; Miao and St Clair, 2009; Horning et al., 2015). 
Interestingly, Mn2+ is paramagnetic, and Mn complexes have been proposed as contrast 
agents for magnetic resonance imaging (MRI) (Mendonça-Dias et al., 1983; Fornasiero et 
al., 1987). 
MRI is a powerful diagnostic methodology in clinical medicine that produces accurate 70 
images in vivo (Brown and Semelka, 2010); however, its inherent low sensitivity often 
requires the use of contrast agents. Mn2+ is able to reduce T1 relaxation times of water, 
thus resulting in positive MRI contrast enhancement (Nordhoy et al., 2004; Lelyveld et al., 
2011). Unfortunately, Mn complexes easily dissociate after administration with the 
formation of free Mn2+, resulting in Mn poisoning (Santamaria, 2008). 75 
With the nanotechnology surge in recent years, different types of Mn-based nanoparticles 
(Nps) have been developed to be used as MRI contrast agent. In particular, MnO Nps 
obtained by thermal decomposition of Mn-oleate complex and then encapsulated in a 
biocompatible shell proved to be very promising as both MRI contrast agents and drug 
carriers (Na et al., 2007; Shin et al., 2009; Howell et al., 2013; Lee et al., 2014).  80 
However, to design effective and safe administration procedures of these interesting Mn-
based Nps for therapeutic and diagnostic applications, preliminary studies on target cells 
are required. The studies are aimed at clarifying Nps uptake mechanism(s), intracellular 
distribution, interactions with cell organelles and intracellular persistence (with special 
attention to their degradation pathways). It is also necessary to investigate the possible 85 
occurrence of structural and functional alterations related to the permanence of Nps in the 
intracellular milieu.  
In this work, we focused our attention on Mn-based Nps encapsulated in a phospholipidic 
shell (PL-MnO Nps), which proved to efficiently act as MRI contrast agents (Howell et al., 
2013), with the aim to explore, in an in vitro model, their biocompatibility at short and long 90 
term, as well as their internalization kinetics and intracellular distribution and stability by 
combining flow cytometry, confocal and transmission electron microscopy. 
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2. Materials and methods 
 95 
2.1. Materials 
 
The phospholipids were provided by Avanti Polar-Lipids (distributed by Spectra 2000, 
Rome, Italy). The chemicals, Trypan blue, Hoechst 33258 and PKH67 Green Fluorescent 
Cell Linker were obtained from Sigma-Aldrich (Milan, Italy). All the solvents used were of 100 
analytical grade, purchased from Carlo Erba Reagenti (Milan, Italy). Lissamine™ 
rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium 
salt (rhodamine-DHPE) were from Invitrogen (Life Technologies, Monza, Italy). Dulbecco 
Modified Eagles Medium (DMEM), fetal calf serum, glutamine, penicillin, streptomycin and 
trypsin were purchased from Euroclone (Milan, Italy). Osmium tetroxide, potassium 105 
ferrocyanide, Epon resin components and grids were purchased from Electron Microscopy 
Sciences (Società Italiana Chimici, Rome, Italy). The human autoimmune serum 
recognizing lysosomal proteins was a kind gift from Dr. C. Alpini (Alpini et al., 2012); the 
Alexa 488-conjugated anti-human IgG secondary antibody was provided by Molecular 
Probes (Invitrogen, Milan, Italy). 110 
 
2.2 Preparation of MnO nanoparticles encapsulated in a phospholipidic shell (PL-MnO 
Nps) 
 
MnO nanoparticles were prepared following the methods described previously with minor 115 
modifications (Howell et al., 2013; Park et al., 2004). Initially Mn-oleate complex was 
prepared heating at 70°C overnight 2 g (13 mmol) of manganese sulfate and 6.1 g (20 
mmol) of sodium oleate dissolved in a mixture of 7.5 ml of ethanol, 10 ml of distilled water 
and 17 ml of n-hexane. At the end of the reaction, the solution was washed three times 
with distilled water. The upper organic layer was dried over anhydrous magnesium 120 
sulphate and evaporated under reduced pressure giving the Mn-oleate complex as a red 
waxy solid. 
To prepare MnO nanoparticles 1.24 g of the previously prepared Mn-oleate complex (2 
mmol) was dissolved in 14 ml of 1-octadecene and the mixture was degassed at 70 °C for 
1 h under vacuum with vigorous stirring. The solution was then heated to 300°C and 125 
maintained at this temperature for 90 min under nitrogen atmosphere. During the reaction, 
as the temperature reached 300°C, the red solution became transparent and then turned 
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to pale green. The solution was then cooled to room temperature, and 15 ml of a mixture 
of dichloromethane and acetone (2:4 v/v) was added and the obtained precipitate was 
centrifuged at 4000 rpm at 4°C for 10 min. Supernatants were eliminated and precipitation 130 
and centrifugation procedure was repeated several times.  
Finally, to encapsulate MnO nanoparticles in a lipidic shell, a mixture of 2.9 mg of 1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC) and 0.1 mg of 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (mPEG-DSPE) was 
dissolved in 1 ml of chloroform and added to 1.5 mg of the previously prepared MnO 135 
nanoparticles. The solvent was then evaporated and the resulting lipid film was dried 
under vacuum overnight, then hydrated with 2 ml of water: this suspension was vortexed 
and bath sonicated for 120 min. The MnO nanoparticles encapsulated in a phospholipidic 
shell (PL-MnO Nps) were then filtered through a 0.45 micron syringe filter. 
For the in vitro studies, fluorescent labelled PL-MnO Nps were prepared as described 140 
previously with the addition of 0.2 mg of rhodamine-DHPE to the lipid mixture in chloroform 
before lipid film preparation. 
 
2.3 Characterization of nanoparticles  
 145 
Fourier transform infrared spectra (FTIR) were recorded on a Bruker IFS 28 
spectrophotometer equipped with a DTGS detector, working with 4 cm-1 resolution over 
128 scans in the Mid IR (MIR) interval (4000-400 cm-1). Measurements were carried out on 
MnO nanoparticles before encapsulation in the lipidic shell, working in ATR (Attenuated 
Total Reflectance) mode. A MKII Golden Gate (Specac) equipped with diamond crystal at 150 
45° was employed for the measurements.  
High Resolution Transmission Electron Microscopy (HRTEM) analyses were performed by 
means of a JEM 3010-UHR microscope (JEOL Ltd.) operating at 300 kV. For the 
measurements, MnO nanoparticles and PL-MnO Nps were dispersed on a copper grid 
coated with a perforated carbon film. The size distribution of the samples was elaborated 155 
by employing the software Comptage de Particules v 2.0. In the case of MnO 
nanoparticles a statistically representative number of particles (ca. 400 particles) was 
measured, and the results are indicated as mean particle diameter ± standard deviation 
(dm ± STD). Size measured in the case of PL-MnO Nps is not statistically relevant due to 
small number of objects measured. 160 
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Thermogravimetric analysis (TGA) was carried out on PL-MnO Nps on a TAQ600 (TA 
instruments) by heating the samples, after equilibration, from 30 to 700°C at a rate of 
10°C/min. Once the target temperature was reached, an isotherm was run for 5 min in air 
in order to burn carbonaceous residues from pyrolysis reactions. 
The mean particle size and polydispersity index of the PL-MnO Nps were determined at 165 
20°C by quasi-elastic light scattering (QELS) using a nanosizer Coulter® N4MD (Coulter 
Electronics, Inc., Hialeah, FL). The selected angle was 90°, and the measurement was 
performed after dilution of the samples in MilliQ® water. Each measurement was carried 
out in triplicate. Zeta potential was determined using a Zetasizer (Zeta Potential Analyzer 
Ver. 2.17, Brookhaven Inst. Corp., Holtsville, NY). 170 
The nanoparticles were also analyzed for physical stability in the storage conditions at 4°C 
evaluating at different interval times the diameter value. 
 
2.4 In vitro cell culture 
 175 
HeLa cells (5x104) were grown in DMEM supplemented with 10% (v/v) fetal calf serum, 
1% (w/v) glutamine, 100 U of penicillin and 100 μg/mL streptomycin, at 37°C in a 5% CO2 
humidified atmosphere. Cells were trypsinized when subconfluent and seeded on glass 
coverslips in 6 multiwell dishes for fluorescence and transmission electron microscopy.  
Two days after seeding, the initial medium was replaced with fresh medium plus 180 
fluorescent PL-MnO Nps to obtain different Mn-oleate concentrations (see below). The 
incubation time with PL-MnO Nps varied from 10 min to 24 h. For long-term studies, the 
cells were kept in the medium containing PL-MnO Nps for 24 h, and then this medium was 
replaced with fresh medium without nanoparticles (retrieval). After retrieval, the cells were 
further grown for 24, 48, and 72 h.  185 
 
2.5 Cell viability assay 
 
Based on previous studies (Na et al., 2007; Howell et al., 2013) three concentrations of 
PL-MnO Nps (0.006, 0.06 and 0.6 µg/ml) were tested in cultured cells. Cell viability was 190 
estimated at both short (1 and 2 h) and long term (24 and 48 h).  
At the end of each incubation time, HeLa cells were detached by mild trypsinization 
(0.25% trypsin in PBS containing 0.05% EDTA) and stained in suspension for 2 min with 
0.1% Trypan blue in the culture medium: cells that were permeable to Trypan blue were 
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considered as non-viable and their percentage was estimated by microscope counting on 195 
a Burker hemocytometer; cell samples not exposed to nanoparticles were considered as 
controls. Results were expressed as the mean ± standard deviation (STD) of three 
independent experiments.  
 
2.6 Flow cytometry 200 
 
For these experiments, the cells were exposed to PL-MnO Nps (0.6 µg/ml concentration) 
for 15 to 240 min. At each time-point, cell samples were detached by mild trypsinization, 
centrifuged and re-suspended in fresh complete medium at the concentration of 2.5x105 
cells per ml. Measurements were taken with a Partec PAS III flow cytometer using an 205 
argon laser excitation at 488 nm (power 200 mW) and a 550-600 band-pass filter for 
rhodamine fluorescence detection. The cells were identified based on their forward and 
side scatters, and at least 20,000 cells were measured for their fluorescence signal in the 
histogram region used for calculations. As a control for possible cell autofluorescence and 
thresholding, untreated HeLa cell samples were processed and measured, in parallel with 210 
the PL-MnO Np-treated cell specimens. 
 
2.7 Analysis of nanoparticles intracellular distribution  
 
At each time, HeLa cells were fixed for fluorescence microscopy with 4% (v/v) 215 
paraformaldehyde in PBS, pH 7.4 (30 min at 4°C). 
The samples were stained for DNA with Hoechst 33258 (1 μg/ml in PBS for 5 min), 
counterstained with 0.1% Trypan blue in PBS for 2 min, rinsed in PBS, and mounted in a 
1:1 mixture of glycerol:PBS. This allowed to visualize the intracellular presence of 
fluorescent PL-MnO Nps and verify their possible intranuclear location. 220 
In order to investigate whether the PL-MnO Nps enter the cells via endocytosis, some cell 
samples were pre-incubated with PKH67 Green Fluorescent Cell Linker to stain the 
plasma membrane (and the resulting endocytotic vesicles) prior to being briefly (5 min) 
incubated with the PL-MnO Nps; the cell samples were finally fixed and processed for 
fluorescence microscopy as described above. This procedure allowed to detect possible 225 
co-localization of the green (endocytotic vesicles) and red (Nps) fluorescence signals. 
To elucidate whether internalized PL-MnO Nps undergo degradation in lysosomes, some 
cell samples were immunolabelled with a human autoimmune serum recognizing 
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lysosomal proteins, diluted 1:500 in PBS. After 60 min incubation at room temperature, 
immunolabelling was revealed with an Alexa 488-conjugated anti-human IgG antibody 230 
diluted 1:200 in PBS. The DNA was counterstained with 0.1 µM Hoechst 33258 in PBS for 
5 min, and cells were mounted in a 1:1 mixture of glycerol:PBS as above. 
An Olympus BX51 microscope (Olympus Italia Srl, Milan, Italy) equipped with a 100W 
mercury lamp was used under the following conditions: 540 nm excitation filter (excf), 580 
nm dichroic mirror (dm), and 620 nm barrier filter (bf) for rhodamine; 450–480 nm excf, 235 
500 nm dm, and 515 nm bf, for Alexa 488 and PKH67; 330–385 nm excf, 400-nm dm, and 
420 nm bf, for Hoechst 33258. Images were recorded with an Olympus Magnifire digital 
camera system (Olympus Italia Srl, Milan, Italy), and stored on a PC by the Olympus 
software for processing and printing.  
For confocal laser scanning microscopy, a Leica TCS-SP system mounted on a Leica 240 
DMIRBE inverted microscope (Leica Microsystems Italia, Milan, Italy) was used; for 
fluorescence excitation, an Ar/Vis laser at 488 nm for FITC, a He/Ne laser at 543 nm for 
Alexa 594, and an Ar/UV laser at 364 nm for Hoechst 33258 were used. Spaced (0.5 µm) 
optical sections were recorded using a 63x oil immersion objective. Bright-field images 
were also taken. Images were collected in the 1024x1024 pixel format, stored on a 245 
magnetic mass memory and processed by the Leica confocal software. 
For transmission electron microscopy, HeLa cells were exposed to rhodamine-labelled PL-
MnO Nps as above, and processed for 3,3' diaminobenzidine (DAB) photo-oxidation: this 
is a histochemical technique based on the capability of an excited fluorophore to induce 
DAB oxidation into a stable electron-opaque precipitate (Maranto, 1982). Briefly, the cells 250 
were fixed with 2.5% (v/v) glutaraldehyde and 2% (v/v) paraformaldehyde in 0.1 M 
phosphate buffer, pH 7.4, at 4°C for 1h, washed and incubated with 3,3' diaminobenzidine 
(DAB) (20 mg/10 ml in Tris HCl 0.05 M, pH 7.6) under irradiation with two 8W Osram 
Blacklite 350 lamps for 2 h at room temperature (these lamps emits with high intensity in 
the spectral range between 430 and 470 nm, thus being suitable for rhodamine excitation); 255 
the cells were then post-fixed with 1% osmium tetroxide and 1.5% potassium ferrocyanide 
at room temperature for 1 h, dehydrated with acetone and embedded in Epon. Samples 
processed as described above, but omitting either DAB incubation or exposure to the 
excitation light were used as control. 
Ultrathin sections were weakly stained with 2.5% uranyl acetate in water, and observed in 260 
a Philips Morgagni transmission electron microscope (FEI Company Italia Srl, Milan, Italy) 
operating at 80kV and equipped with a Megaview II camera for digital image acquisition.  
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3. Results 
 265 
3.1 Preparation of PL-MnO Nps 
 
Nanoparticles composed of MnO core surrounded by a hydrophobic surface layer of oleic 
acid were synthesized by the thermal decomposition of the previously prepared Mn-oleate 
complex. The purified MnO nanoparticles were dispersible in many organic solvents such 270 
as n-hexane and chloroform. In order to increase their hydrophilicity and biocompatibility, a 
hydrophilic shell was created by adding the MnO nanoparticles to a mixture of DSPC and 
mPEG-DSPE dissolved in chloroform. The suspension was evaporated under vacuum and 
the dry lipid film was hydrated, sonicated and filtered to give the corresponding PL-MnO 
Np. 275 
 
3.2 Characterization of nanoparticles 
 
MnO nanoparticles were characterized by FTIR spectroscopy and HRTEM techniques. 
The FTIR spectrum of MnO nanoparticles is reported in Figure 1a. It is characterized by 280 
intense bands in the spectral range of C-H stretching modes (nCH), with a weaker band in 
the region of C-H bending ones (dCH). More in detail, bands at 2955 (shoulder), 2922 and 
2852 cm-1 are related to asymmetric nCH3, asymmetric and symmetric nCH2 vibrations, 
respectively. The weak band at 1461 cm-1 is the corresponding dCH2 (scissor vibration). 
These bands (typical of saturated hydrocarbons) confirm the presence of a hydrophobic 285 
surface layer on MnO nanoparticles. 
HRTEM images acquired on MnO nanoparticles are reported in Figure 1b-c. These consist 
of well dispersed crystalline nanoparticles, with prismatic shape and well defined edges. A 
bimodal size distribution was measured, centered at 6.5 and 13 nm, with average size of 
11 ± 4 nm. The magnification reported in Figure 1d allows to appreciate the presence of 290 
lattice planes. Fourier Transform analysis of the high resolution images allowed to 
measure the crystal lattice distances typical of tetragonal Mn3O4 phase.  
The same technique was employed to analyze PL-MnO Nps (Figure 2), showing that after 
inclusion in phospholipidic shells the same primary MnO nanoparticles are present (as 
seen in the high magnification image, panel c), but they form larger aggregates, around 295 
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120 nm in diameter. TGA on the same material showed a weight loss around 64%, 
assigned to the thermal decomposition of the hydrophobic layer and phospholipidic shell. 
As found by QELS analysis, PL-MnO Nps dispersed in water showed a mean diameter of 
about 120 nm (in very good agreement with TEM analysis). The surface charge was 
evaluated by Z potential analysis showing a slightly negative value of -6.8 mV. After 4 300 
weeks of storage at 4°C no appreciable size change of PL-MnO Nps (< 2%) was detected 
by QELS. 
 
3.3 Cell viability 
 305 
The incubation of cells with PL-MnO Nps for 10 min up to 48 h did not increase cell 
mortality: the Trypan blue exclusion test showed that dead cells were always less than 1% 
of the total cell population for each nanoparticle suspension at no variance with control 
samples not exposed to nanoparticles. 
 310 
3.4 Flow cytometry 
 
In Figure 3 the cytometric results of a typical experiment are shown: consistent with the 
microscopic evidence (Figure 3, upper row), PL-MnO Nps proved to be rapidly internalized 
by HeLa cells and a progressive increase in the mean fluorescence intensity was observed 315 
from 15 to 240 min of treatment (Figure 3, lower row). 
 
3.5 Intracellular distribution of PL-MnO Nps  
 
Fluorescence microscopy confirmed that, after 15 min incubation, PL-MnO Nps already 320 
entered the cells and their amount progressively increased with the incubation time (Figure 
3). PL-MnO Nps were found throughout the cytoplasm, progressively accumulating in 
perinuclear position; however, they were never observed inside the cell nucleus (Figure 4). 
When the cell cultures were pre-incubated with PHK67 to stain the plasma membrane 
before being incubated with rhodamine-labelled PL-MnO Nps, no red-fluorescing 325 
nanoparticles were found to co-locate with green-fluorescing intracellular membranes 
(Figure 4b), thus suggesting that endocytosis does not represent the preferential 
internalization mechanism. 
11 
 
From 24 h to 72 h after PL-MnO Np retrieval, similar intracellular distribution was 
observed: they were exclusively found throughout the cytoplasm in both interphasic and 330 
mitotic cells (not shown); accordingly, rodamine-labelled PL-MnO Nps were never found to 
co-localize with the nuclear or chromosomal fluorescent signal for DNA. 
The fluorescence signals of PL-MnO Nps and lysosomes were only occasionally found to 
co-localize at the different incubation times, indicating that most of the internalized Nps 
escape lysosomal degradation (Figure 4b, c).  335 
At transmission electron microscopy, PL-MnO Nps appeared as roundish, moderately 
electron-dense structures evidently labelled with the fine electron dense granular reaction 
product of DAB photo-oxidation (Figure 5). At all times, free-ranging PL-MnO Nps were 
found in the cytosol (Figure 5); they were ubiquitously distributed in the cytoplasm, mostly 
occurring in the perinuclear region, but were never found in contact with any organelle 340 
(Figure 5a). After 24h, a few PL-MnO Nps were observed inside dual-membrane-bounded 
autophagosomes (Figure 5c), and some Nps remnants still showing the photo-oxidation 
product were found inside residual bodies (Figure 5d). 
The ultrastructural analysis demonstrated that no morphological alteration or damage of 
cell organelles ever occurred. 345 
 
4. Discussion  
 
MnO-based Nps encapsulated in lipidic shells previously proved to be able to enhance T1 
MRI contrast and deliver DNA and/or drugs to target cells in vitro and in vivo (Howell et al., 350 
2013). These Nps are particularly interesting because the Mn oxide core is very 
hydrophobic and must be coated for in vivo use; to this aim Mn containing nanocomposite 
were encapsulated in phospholipids containing also a small amount of PEG, thus 
significantly improving their water solubility, stability (no change in mean particle size was 
found after one month of storage), biocompatibility and bioavailability. Accordingly, the 355 
viability assay carried out in our in vitro system revealed that PL-MnO Nps administration 
did not increase cell mortality after both short (1-2 h) and long (1-2 days) incubation times, 
even at the highest Nps concentration tested. Checking cell viability after short exposure 
time is essential to avoid underestimation of possible Nps negative effects: it is, in fact, 
possible that some cells undergo damage/death immediately after Nps exposure, but the 360 
surviving population will continue to expand so that, at long term, no effect will be 
detectable by viability tests. Aiming at an in vivo administration of PL-MnO Nps for 
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diagnostic purposes, it is mandatory to avoid cell damage and/or death since this may 
trigger an inflammatory response in tissues and organs of the patient receiving the 
nanoparticulated MRI contrast agent (Rock and Kono, 2008; Kono et al., 2014). 365 
Our analyses by flow cytometry provide the first experimental evidence of the 
internalization kinetics of PL-MnO Nps: they are able to enter the cells very rapidly since 
already after a 15 min exposure many cells showed a detectable fluorescent signal, and 
after 1 h the signal reached its maximum. These data explains the efficient PL-MnO Np 
uptake and accumulation at the target sites previously reported in vivo, essential to 370 
produce MRI contrast enhancement (Na et al., 2007; Howell et al., 2013).  
Our microscopy analyses also provide original information about the internalization 
mechanisms and intracellular fate of PL-MnO Nps; in fact, combining fluorescence and 
transmission electron microscopy allowed us to monitor PL-MnO Nps from their uptake to 
degradation. In particular, DAB photo-oxidation (Maranto, 1982) was confirmed to be an 375 
especially suitable method to unambiguously visualize fluorescently-labeled nanoparticles 
at transmission electron microscopy (Malatesta et al., 2012, 2014). The application of this 
technique in our experimental model allowed to overcome the limit due to the moderate 
electron density of native PL-MnO Nps, which makes them hardly distinguishable from the 
cytosolic milieu, and to unequivocally identify the Nps even inside residual bodies i.e., after 380 
they underwent lytic degradation and had therefore lost their typical morphology. 
Our observations demonstrated that PL-MnO Nps rapidly enter the cells and occur in the 
cytoplasm as single units, thus proving that PEG coating proficiently prevents Nps 
aggregation in the culture medium and at the cell surface. The cellular uptake probably 
takes place by fusion with the plasma membrane, as demonstrated by both fluorescence 385 
microscopy (the signals of nanoparticles and endosomal membrane never overlapped) 
and transmission electron microscopy (the nanoparticles were never observed inside 
endosomes). It is known that cellular uptake of anionic, neutral and hydrophobic Nps may 
occur by lipid raft-mediated endocytosis, which includes hydrophobic internalization via 
lipid membrane fusion as well as uptake of lipophilic and anionic groups via scavenger 390 
receptor-mediated membrane fusion: both mechanisms bypass the endo-lysosomal route 
thus facilitating the intracellular permanence of Nps (Lanza et al., 2011). Since lipid rafts 
are characteristics of many human cancer cells (Mollinedo and Gajate, 2015; Nicolson, 
2015), the use of PL-MnO Nps could represent an advantage for both diagnostic and 
therapeutic purposes. 395 
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Once inside the cell, PL-MnO Nps occur free (i.e., devoid of a surrounding membrane) in 
the cytosol preserving their original morphology and without establishing spatial 
relationships with any particular cell organelle or structure. PL-MnO Nps migrate from the 
cell periphery and accumulate in the perinuclear region, where they persist for long time 
without showing alterations of their structure, thus indicating that cytosolic enzymes are 400 
unable to attack these nanoconstructs. This also implies that MnO and/or Mn ions are not 
released by the PL-MnO Nps, thus explaining the absence of ultrastructural alterations of 
cell organelles (e.g. Klimis-Zacas, 1993; Villalobos et al., 2009; Mertz, 2013) despite the 
long persistence of free Nps in the cytosol. The absence of any intracellular injury also 
proves the high biocompatibility of the organic shell.   405 
By avoiding the endocytic pathways, most of PL-MnO Nps likely escape from a rapid 
degradation due to lysosomal enzymes, as confirmed by the rare co-location of Nps and 
lysosome signals at fluorescence microscopy. However, PL-MnO Nps may undergo the 
autophagic process: as demonstrated by electron microscopy, the Nps are surrounded by 
dual-membrane structures and then enter the lysosomal pathways, being finally found as 410 
DAB-positive remnants inside secondary lysosomes or residual bodies. Therefore, 
although the PL-MnO Nps can persist inside the cells for some days, they are finally 
degraded through physiological pathways without perturbing cell metabolism, thus further 
demonstrating their high biocompatibility and safety. However, the long-lasting intracellular 
permanence of PL-MnO Nps may represent a risk in the case of multiple administrations; 415 
therefore, this must be taken into account when using these Nps for both diagnostic and 
therapeutic purposes. On the other hand, the capability of PL-MnO Nps to maintain for 
long time their structural integrity in the intracellular milieu makes them especially suitable 
for sustained drug release. 
The intracellular presence of PL-MnO Nps 72 h after they had been removed from the 420 
medium demonstrates that, similarly to other Nps (Guan et al., 2012; Malatesta et al., 
2015), they are able to pass from mother to daughter cells through mitotic cycles. 
However, PL-MnO Nps were never found inside the nucleus, even after long time 
incubation, demonstrating not only that these Nps are unable to pass through the nuclear 
envelope (as expected due to their size being incompatible with their passage through the 425 
nuclear pore complex), but also that they are excluded from the newly formed nuclei at the 
end of mitosis (contrary to what observed for some polymeric Nps, see e.g. Guan et al., 
2012; Malatesta et al., 2015). It should be underlined that entering the cell nucleus may 
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represent a risk because of the possible interactions of Nps with nucleic acids and/or 
nuclear factors that, in a cascade effect, could unpredictably impair multiple cell functions. 430 
In conclusion, our study demonstrated that PL-MnO Nps undergo rapid and massive cell 
internalization, and persist for long times inside the cytoplasm, without being cytotoxic or 
inducing subcellular damage: based on the results with this cell model in vitro, PL-MnO 
Nps thus proved to be suitably biocompatible, and may be envisaged as very promising for 
therapeutic and diagnostic applications in vivo, as drug carriers or contrast agent for MRI. 435 
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Figure captions 525 
 
Figure 1. Characterization of MnO nanoparticles. a) FTIR spectrum, b-d) HRTEM images 
acquired at b) 60000 X (bar 20 nm); c) 100000 X (bar 20 nm) and d) 400000 X (bar 5 nm). 
 
Figure 2. Characterization of PL-MnO Nps. a)-c) HRTEM images acquired at a) 30000 X 530 
(bar 50 nm); b) 80000 X (bar 20 nm) and c) 400000 X (bar 5 nm). d) Thermogravimetric 
profile. 
 
Figure 3. Internalization kinetics of PL-MnO Nps. HeLa cells after treatment with PL-MnO 
Nps for 15 to 240 min. The micrographs taken at conventional fluorescence microscopy 535 
(upper row) show that the intracellular fluorescent nanoparticles apparently increase in 
number for increasing treatment times. Bar 20 µm. This is consistent with the cytometric 
histograms (lower row), where the reference histograms (black line) corresponded to the 
negligible background fluorescence of control cell samples in the absence of 
nanoparticles. 540 
 
Figure 4. Fluorescence microscopy analysis of PL-MnO Nps intracellular distribution. 
Micrographs of HeLa cells taken at confocal (a ,b) and conventional (c, d) fluorescence 
microscopy. a) After 3 h incubation, red fluorescent PL-MnO Nps are distributed in the 
whole cytoplasm, especially in the perinuclear region, but are absent from nuclei (N). The 545 
red fluorescent signal of nanoparticles has been merged with the brighfield image. b) Cells 
pre-incubated with the PKH67 green-fluorescing dye to label the plasma membrane and 
endocytotic vesicles, then incubated for 5 min with red fluorescent PL-MnO Nps (arrows): 
red fluorescence never co-locates with green fluorescent endosomes. DNA is stained with 
Hoechst 33258 (blue fluorescence). c, d) Cells incubated with red fluorescent PL-MnO Nps 550 
for 2 h (c) and 72 h after retrieval (d); immunolabelling for lysosomes (green fluorescence): 
the green and red fluorescence signals rarely overlap (thin arrow and inset), demonstrating 
that most of the internalized Nps escape enzymatic degradation. DNA is stained with 
Hoechst 33258 (blue fluorescence). Bars 20 µm. 
 555 
Figure 5. Transmission electron microscopy analysis of PL-MnO Nps intracellular 
distribution. Micrographs of HeLa cells incubated with fluorescent PL-MnO Nps and 
submitted to DAB photo-oxidation; note the fine electron dense granular reaction product 
20 
 
in all nanoparticles. a) Six PL-MnO Nps (arrows) occur free in the cytoplasm without 
making contact with any organelle. N, nucleus; m, mitochondria; g, Golgi apparatus; r, 560 
ribosomes. b) A PL-MnO Np (arrow) where the phospholipidic shell is recognizable as 
electron dense concentric lines at the nanoparticle periphery. c) A PL-MnO Np (arrow) is 
partially surrounded by an autophagic dual membrane. d) An autophagic residual body 
containing heterogeneous material: a PL-MnO Np remnant (arrow) is still detectable 
thanks to the DAB photo-oxidation precipitates. Bars 200 nm. 565 
